Revenue: As of FY2026 Q2, the actual value is USD 1.442 B, beating the estimate of USD 1.419 B.

EPS: As of FY2026 Q2, the actual value is USD 0.35, beating the estimate of USD 0.3326.

EBIT: As of FY2026 Q2, the actual value is USD 88.01 M.

Option Care Health, Inc. reported key financial metrics for the second quarter and six months ended June 30, 2026.

Second Quarter 2026 Financial Highlights

Net revenue for the second quarter ended June 30, 2026, was $1,442 million, representing a 1.9% increase year-over-year. GAAP net income rose by 6.7% compared to the prior year, reaching $53.9 million. Adjusted EBITDA increased by 3.0% year-over-year to $117.5 million. Cash provided by operating activities during the second quarter was $184 million. The company repurchased $150 million of its outstanding shares in the quarter.

Six Months Ended June 30, 2026 Financial Performance

Net revenue for the six months ended June 30, 2026, was $2,793,054 thousand, up from $2,749,057 thousand in the same period of 2025. Cost of revenue was $2,263,789 thousand, compared to $2,216,962 thousand in 2025. Gross profit slightly decreased to $529,265 thousand from $532,095 thousand in 2025.

Operating costs and expenses totaled $371,580 thousand, a slight increase from $370,197 thousand in 2025. This included selling, general and administrative expenses of $331,065 thousand ($330,275 thousand in 2025), restructuring, acquisition, integration and other expenses of $8,156 thousand ($7,935 thousand in 2025), and depreciation and amortization expense of $32,359 thousand ($31,987 thousand in 2025). Operating income for the period was $157,685 thousand, down from $161,898 thousand in 2025.

Total other (expense) income was - $22,695 thousand, an improvement from - $29,481 thousand in 2025. This included net interest expense of - $27,324 thousand (- $27,678 thousand in 2025) and other, net income of $4,629 thousand (- $1,803 thousand in 2025). Income before income taxes increased to $134,990 thousand from $132,417 thousand in 2025. Income tax expense was $35,734 thousand, compared to $35,152 thousand in 2025. Net income for the six months was $99,256 thousand, up from $97,265 thousand in 2025.

Cash Flow

Net cash provided by operating activities for the six months ended June 30, 2026, significantly increased to $171,485 thousand from $83,119 thousand in the prior year period. Key changes contributing to this included a - $37,941 thousand change in accounts receivable, net, and a $71,544 thousand change in inventories.

Net cash used in investing activities was - $21,000 thousand, primarily due to - $20,123 thousand for the acquisition of property and equipment. This compares to - $135,713 thousand in the prior year, which included - $117,247 thousand for business acquisitions. Net cash used in financing activities amounted to - $189,342 thousand, including - $170,545 thousand for the purchase of company stock and related excise taxes.

Balance Sheet

As of June 30, 2026, total assets were $3,378,777 thousand, a decrease from $3,455,769 thousand at year-end 2025. Cash and cash equivalents decreased to $193,767 thousand from $232,624 thousand at year-end 2025. Inventories were $399,605 thousand, down from $471,149 thousand. Goodwill remained flat at $1,606,743 thousand. Total liabilities decreased to $2,118,879 thousand from $2,129,376 thousand at year-end 2025. Long-term debt, net, was $1,152,040 thousand, slightly down from $1,154,052 thousand. Stockholders’ equity decreased to $1,259,898 thousand from $1,326,393 thousand at year-end 2025.

Outlook / Guidance

For the full year 2026, Option Care Health, Inc. anticipates net revenue between $5.675 billion and $5.775 billion, with Adjusted EBITDA projected to range from $480 million to $495 million. The company expects cash provided by operating activities to be at least $320 million for the full year. For the third quarter of 2026, the company projects sequential net revenue growth in the low to mid single-digits and sequential Adjusted EBITDA growth in the mid single-digits compared to the second quarter of 2026.